Novo Nordisk A/S (NVO)

98.46 -1.17 (-1.17%)
Real-time Cboe USD Disclaimer

NVO Ratios

Valuation Ratios
Net Debt -21,058
Price to Cash Flow 30.81 21.55
Price to Book 32.95 7.11
Price to Tangible Book 83.9 530.32
Profitability - -
Per Share Data
Book Value/Share 20.79 175.27
Tangible Book Value/Share 8.32 20.3
Cash/Share 6.74 27.89
Management Effectiveness - -
EPS(MRQ) vs Qtr. 1 Yr. Ago 57.66% 15.07
Sales (MRQ) vs Qtr. 1 Yr. Ago 28.89% 16.3
Financial Strength
Quick Ratio 0.58 0.95
Current Ratio 0.82 1.41
LT Debt to Equity 21.43% 108.7
Total Debt to Equity 28.54% 115.63
Efficiency - -
Dividend - -
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles